NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country - although it has had to drop a 2025 target date because of ...
Training a large artificial intelligence model is expensive, not just in dollars, but in time, energy, and computational ...